ArticleIn vivo (Athens, Greece)

Efficacy and Safety of Vildagliptin for Type 2 Diabetes in Patients With Diabetic Kidney Disease.

Akira Mima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.